bioAffinity Technologies receives US patent allowance for lung cancer test

Go back to bioAffinity Technologies receives US patent allowance for lung cancer test
(NASDAQ: BIAF) Delayed: 10.50 +1.57 (17.58%)
Previous Close $8.93    52 Week High
Open $10.90    52 Week Low
Day High $12.32    P/E N/A 
Day Low $10.09    EPS
Volume 10,429,402       

(NASDAQ: BIAFW) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High
Open $0.63    52 Week Low
Day High $0.64    P/E N/A 
Day Low $0.55    EPS
Volume 10,514